☆ 4.7 Article

Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Critical Care Medicine

Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19

Daniel E. Leisman et al.

Summary: The contribution of alveolar and endothelial injury may vary during the progression of COVID-19. Increased endothelial injury markers are associated with cardiorenovascular injury and 28-day outcomes, while alveolar injury markers increase earlier.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection

Letter Critical Care Medicine

Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial

Anthony D. Postle et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection

Article Critical Care Medicine

Constant VT Ventilation and Surfactant Dysfunction An Overlooked Cause of Ventilator-induced Lung Injury

Richard K. Albert

Summary: This Perspective summarizes the mechanisms by which continuous volume-targeted ventilation (CVTV) causes ventilator-induced lung injury (VILI) by affecting surfactant function.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection

Editorial Material Medicine, General & Internal

Research in the Context of a Pandemic

H. Clifford Lane et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies

Omar Hasan Ali et al.

Summary: This study found that severe COVID-19 patients have a vigorous total IgA response and higher levels of IgA antibodies, which may be associated with complications of severe illness. Additionally, severe illness in COVID-19 patients is significantly correlated with elevated levels of anticardiolipin antibodies, suggesting a potential link to systemic autoimmunity.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Letter Respiratory System

Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient

Matthias Ochs et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Towards the Molecular Mechanism of Pulmonary Surfactant Protein SP-B: At the Crossroad of Membrane Permeability and Interfacial Lipid Transfer

Marta Martinez-Calle et al.

Summary: SP-B and SP-C play important roles in the permeability of surfactant membranes, with SP-C and anionic phospholipids identified as essential modulators for maintaining native-like permeability features. Proper permeability through membrane assemblies is crucial for the overall role of surfactant in maintaining alveolar equilibrium.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Pathology

The pulmonary pathology of COVID-19

Hans Bosmuller et al.

Summary: The lung is the primary organ affected by severe coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2, with lung damage being the leading cause of death in most patients. Pathological features of fatal COVID-19 include early changes like edema, epithelial damage, and capillaritis/endothelialitis, progressing to exudative diffuse alveolar damage (DAD) in patients with respiratory insufficiency. These features are not specific to COVID-19 and can be found in other disorders, while clinically, early severe COVID-19 stages are characterized by high viral load, lymphopenia, pro-inflammatory cytokine secretion, and hypercoagulability.

VIRCHOWS ARCHIV (2021)

Add to Collection

Article Multidisciplinary Sciences

Diverse functional autoantibodies in patients with COVID-19

Eric Y. Wang et al.

Summary: COVID-19 patients show increased autoantibody reactivities against immunomodulatory proteins, which may affect immune function and lead to different clinical outcomes.

NATURE (2021)

Add to Collection

Article Critical Care Medicine

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Sanjay Ramakrishnan et al.

Summary: The study found that early administration of inhaled budesonide reduced the likelihood of needing urgent medical care and accelerated recovery time in patients with early COVID-19.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome

Sergey N. Avdeev et al.

Summary: Inhaled surfactant therapy in patients with COVID-19-associated ARDS significantly improved oxygenation parameters, reduced the need for intensive care and invasive mechanical ventilation, and shortened the duration of non-invasive ventilation and hospital stay.

RESPIRATORY MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

New-onset IgG autoantibodies in hospitalized patients with COVID-19

Sarah Esther Chang et al.

Summary: In hospitalized COVID-19 patients, approximately 50% have detectable autoantibodies primarily targeting autoantigens associated with rare disorders. Additionally, a subset of autoantibodies develop de novo following SARS-CoV-2 infection.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Respiratory System

Prevalence and clinical consequences of atelectasis in SARS-CoV-2 pneumonia: a computed tomography retrospective cohort study

Alvaro Mingote et al.

Summary: The study aimed to estimate the prevalence of atelectasis in SARS-CoV-2 pneumonia patients and its relationship with oxygenation impairment, ICU admission rate, and in-hospital stay length. Results showed that patients with large atelectasis had worse oxygenation and clinical outcomes, requiring more oxygen therapy and ICU admission.

BMC PULMONARY MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality

Mehul D. Patel et al.

Summary: Vaccination against SARS-CoV-2 has the potential to significantly reduce transmission and COVID-19 morbidity and mortality. Simulation outcomes suggest that removing NPIs while vaccines are distributed may result in substantial increases in infections, hospitalizations, and deaths. Higher vaccination coverage with less efficacious vaccines can contribute to a larger reduction in risk of SARS-CoV-2 infection compared with more efficacious vaccines at lower coverage.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Cell Biology

Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients

Philipp K. Buehler et al.

Summary: Superinfections are common among COVID-19 patients with acute respiratory distress syndrome, leading to lower survival rates, longer intensive care treatment, and reduced ventilator-free days despite the use of empirical antibiotic therapy.

CELL REPORTS MEDICINE (2021)

Add to Collection

Article Respiratory System

Surfactant therapy for COVID-19 related ARDS: a retrospective case-control pilot study

Simone Piva et al.

Summary: The study demonstrates that surfactant delivery through bronchoscopy at a dose of 720 mg in 150 ml normal saline is feasible and safe for COVID-19 ARDS patients. Surfactant administration did not cause acute decompensation, may reduce mortality and mechanical ventilation duration in COVID-19 ARDS patients. This supports the need for future randomized clinical trials to evaluate the efficacy of meticulous sub-bronchial lavage with surfactant for COVID-19 ARDS patients.

RESPIRATORY RESEARCH (2021)

Add to Collection

Review Immunology

IgA and the intestinal microbiota: the importance of being specific

Oliver Pabst et al.

MUCOSAL IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Vanessa Monteil et al.

CELL (2020)

Add to Collection

Article Microbiology

Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories

Joshua A. Lieberman et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Mild or Moderate Covid-19

Rajesh T. Gandhi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Letter Immunology

On the molecular determinants of the SARS-CoV-2 attack

Darja Kanduc et al.

CLINICAL IMMUNOLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Add to Collection

Article Critical Care Medicine

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

Giacomo Grasselli et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Immunology

The trinity of COVID-19: immunity, inflammation and intervention

Matthew Zirui Tay et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Review Critical Care Medicine

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19

Wentao Ni et al.

CRITICAL CARE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A cellular census of human lungs identifies novel cell states in health and in asthma

Felipe A. Vieira Braga et al.

NATURE MEDICINE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Protein-lipid interactions and surface activity in the pulmonary surfactant system

Alicia G. Serrano et al.

CHEMISTRY AND PHYSICS OF LIPIDS (2006)

Add to Collection

Article Immunology

The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA

FE Johansen et al.

JOURNAL OF IMMUNOLOGY (2001)

Add to Collection

Article Statistics & Probability

Interval estimation for a binomial proportion - Comment - Rejoinder

LD Brown et al.

STATISTICAL SCIENCE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.